Doxorubicin

CD44 molecule (Indian blood group) ; Homo sapiens







93 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34500160 Fabrication of hyaluronic acid-based micelles with glutathione-responsiveness for targeted anticancer drug delivery. 2022 Jan 15 2
2 35184000 Synergistic H2O2 self-supplying and NIR-responsive drug delivery nanoplatform for chemodynamic-photothermal-chemotherapy. 2022 May 1
3 35216501 Smart Lipid-Polysaccharide Nanoparticles for Targeted Delivery of Doxorubicin to Breast Cancer Cells. 2022 Feb 21 1
4 35277914 Dual-Loaded Liposomes Tagged with Hyaluronic Acid Have Synergistic Effects in Triple-Negative Breast Cancer. 2022 Apr 1
5 35484752 Dual-Targeted Fe₃O₄@MnO₂ Nanoflowers for Magnetic Resonance Imaging-Guided Photothermal-Enhanced Chemodynamic/Chemotherapy for Tumor. 2022 Feb 1 1
6 35501796 Nanozyme-natural enzymes cascade catalyze cholesterol consumption and reverse cancer multidrug resistance. 2022 May 2 2
7 33411349 CD44 enhances adriamycin resistance in chronic myelogenous leukaemia cells K562. 2021 Oct 4
8 33620265 CD44-targeted pH-responsive micelles for enhanced cellular internalization and intracellular on-demand release of doxorubicin. 2021 Dec 7
9 33738958 Overcoming Mfsd2a-Mediated Low Transcytosis to Boost Nanoparticle Delivery to Brain for Chemotherapy of Brain Metastases. 2021 May 1
10 33773562 Curcumin Rescues Doxorubicin Responsiveness via Regulating Aurora a Signaling Network in Breast Cancer Cells. 2021 Mar 1 1
11 33862128 β-Cyclodextrin-grafted hyaluronic acid as a supramolecular polysaccharide carrier for cell-targeted drug delivery. 2021 Jun 1 1
12 34200614 adipoSIGHT in Therapeutic Response: Consequences in Osteosarcoma Treatment. 2021 Jun 10 1
13 34200716 Endosomal pH-Responsive Fe-Based Hyaluronate Nanoparticles for Doxorubicin Delivery. 2021 Jun 10 3
14 34496281 Tumor-targeting pH/redox dual-responsive nanosystem epigenetically reverses cancer drug resistance by co-delivering doxorubicin and GCN5 siRNA. 2021 Nov 6
15 34592836 Targeted delivery of doxorubicin through CD44 aptamer to cancer cells. 2021 Oct 8
16 32328816 Enhancing chemosensitivity of wild-type and drug-resistant MDA-MB-231 triple-negative breast cancer cell line to doxorubicin by silencing of STAT 3, Notch-1, and β-catenin genes. 2020 Sep 1
17 32384236 Cyclic RGD-Conjugated Hyaluronate Dot Bearing Cleavable Doxorubicin for Multivalent Tumor Targeting. 2020 Jun 8 2
18 32760666 Enrichment of CD44 in Exosomes From Breast Cancer Cells Treated With Doxorubicin Promotes Chemoresistance. 2020 4
19 32849878 Enhanced Expression of ABCB1 and Nrf2 in CD133-Positive Cancer Stem Cells Associates with Doxorubicin Resistance. 2020 2
20 33206362 siRNA-mediated silencing of CD44 delivered by Jet Pei enhanced Doxorubicin chemo sensitivity and altered miRNA expression in human breast cancer cell line (MDA-MB468). 2020 Dec 3
21 30782256 Hyaluronic acid-coated single-walled carbon nanotubes loaded with doxorubicin for the treatment of breast cancer. 2019 Feb 1 2
22 30879657 Preparation, characterisation and in vitro and in vivo evaluation of CD44-targeted chondroitin sulphate-conjugated doxorubicin PLGA nanoparticles. 2019 Jun 1 2
23 30960117 β-Cyclodextrin⁻Hyaluronic Acid Polymer Functionalized Magnetic Graphene Oxide Nanocomposites for Targeted Photo-Chemotherapy of Tumor Cells. 2019 Jan 14 2
24 30960121 Hyaluronic Acid-Decorated Laponite® Nanocomposites for Targeted Anticancer Drug Delivery. 2019 Jan 14 2
25 31086900 Targeted co-delivery of the aldose reductase inhibitor epalrestat and chemotherapeutic doxorubicin via a redox-sensitive prodrug approach promotes synergistic tumor suppression. 2019 Jun 25 1
26 31460017 A Composite of Hyaluronic Acid-Modified Graphene Oxide and Iron Oxide Nanoparticles for Targeted Drug Delivery and Magnetothermal Therapy. 2019 May 31 3
27 31623608 pH and redox dual-responsive nanoparticles based on disulfide-containing poly(β-amino ester) for combining chemotherapy and COX-2 inhibitor to overcome drug resistance in breast cancer. 2019 Oct 17 1
28 31746936 Remodeling the tumor microenvironment to improve drug permeation and antitumor effects by co-delivering quercetin and doxorubicin. 2019 Dec 21 1
29 31763810 Dually Active Targeting Nanomedicines Based on a Direct Conjugate of Two Purely Natural Ligands for Potent Chemotherapy of Ovarian Tumors. 2019 Dec 18 5
30 32104479 Exploring the relationship of hyaluronic acid molecular weight and active targeting efficiency for designing hyaluronic acid-modified nanoparticles. 2019 Sep 2
31 29107218 Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer. 2018 Jan 2
32 29352988 STAT3 as a promising chemoresistance biomarker associated with the CD44+/high/CD24-/low/ALDH+ BCSCs-like subset of the triple-negative breast cancer (TNBC) cell line. 2018 Feb 15 2
33 29357289 pH-responsive nanoreservoirs based on hyaluronic acid end-capped mesoporous silica nanoparticles for targeted drug delivery. 2018 May 3
34 29495404 Targeting Glioblastoma Cells Expressing CD44 with Liposomes Encapsulating Doxorubicin and Displaying Chlorotoxin-IgG Fc Fusion Protein. 2018 Feb 26 1
35 29969665 Curcumin loaded selenium nanoparticles synergize the anticancer potential of doxorubicin contained in self-assembled, cell receptor targeted nanoparticles. 2018 Sep 1
36 30100720 Reduction-sensitive CD44 receptor-targeted hyaluronic acid derivative micelles for doxorubicin delivery. 2018 3
37 30201431 Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin. 2018 Oct 15 3
38 30371105 Multifunctional nanogel engineering with redox-responsive and AIEgen features for the targeted delivery of doxorubicin hydrochloride with enhanced antitumor efficiency and real-time intracellular imaging. 2018 1
39 30396468 The CD44 variant induces K562 cell acquired with resistance to adriamycin via NF-κB/Snail/Bcl-2 pathway. 2018 Dec 1
40 27913127 Co-assembly of doxorubicin and curcumin targeted micelles for synergistic delivery and improving anti-tumor efficacy. 2017 Mar 1
41 28422250 A novel nanomissile targeting two biomarkers and accurately bombing CTCs with doxorubicin. 2017 May 4 2
42 28576067 pH-triggered degradable polymeric micelles for targeted anti-tumor drug delivery. 2017 Sep 1 1
43 28743090 NIR and UV-responsive degradable hyaluronic acid nanogels for CD44-targeted and remotely triggered intracellular doxorubicin delivery. 2017 Oct 1 6
44 28819559 Growth inhibitory efficacy of natural products in a model for triple negative molecular subtype of clinical breast cancer. 2017 Sep 1
45 28887972 Dual targeting hyaluronic acid - RGD mesoporous silica coated gold nanorods for chemo-photothermal cancer therapy. 2017 Dec 1 1
46 29371972 CD44 drives aggressiveness and chemoresistance of a metastatic human osteosarcoma xenograft model. 2017 Dec 26 1
47 30023561 Five-Part Pentameric Nanocomplex Shows Improved Efficacy of Doxorubicin in CD44+ Cancer Cells. 2017 Nov 30 2
48 31251139 Self-Assembled Hyaluronic Acid Nanoparticles for pH-Sensitive Release of Doxorubicin: Synthesis and In Vitro Characterization. 2017 Dec 1 2
49 33465938 LAPONITE-Polyethylenimine Based Theranostic Nanoplatform for Tumor-Targeting CT Imaging and Chemotherapy. 2017 Mar 13 1
50 26453853 Carboxymethyl chitosan-mediated synthesis of hyaluronic acid-targeted graphene oxide for cancer drug delivery. 2016 Jan 1 1